Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$351,900
-11.88%
Shares
Shares Volume: 10,000 Shares
Average Share Price: $35.19
INSIDER
Yale Catriona
Chief Development Officer (Officer)
reported on Nov 8 2024
traded on Nov 6 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 74,158 |
| PURCHASES/SALES 1Y | 0 / 11 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $297,077.8 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 2 / 42 |
| P/S VALUE RATIO | 0.143 |
| AVERAGE SALE VALUE | $611,997.04 |
| COMPANY PREVIOUS TRADES |